Tvardi Therapeutics, Inc.
P/E (Price-to-Earnings)
Price
EPS
P/E (Price-to-Earnings)
| Fiscal Year | P/E (Price-to-Earnings) | EPS | Price |
|---|---|---|---|
| Dec 2020 | 3,026.00x | $0.06 | $181.56 |
| Sep 2021 | 894.86x | $0.16 | $146.16 |
| Dec 2024 | 1.15x | $5.31 | $6.12 |
| Sep 2025 | 0.16x | $8.75 | $1.41 |
P/E (Price-to-Earnings)
Price
EPS
P/E (Price-to-Earnings)
| Fiscal Year | P/E (Price-to-Earnings) | EPS | Price |
|---|---|---|---|
| Dec 2020 | 3,026.00x | $0.06 | $181.56 |
| Sep 2021 | 894.86x | $0.16 | $146.16 |
| Dec 2024 | 1.15x | $5.31 | $6.12 |
| Sep 2025 | 0.16x | $8.75 | $1.41 |